Skip to main content
Cytogen, Inc. logo

Cytogen, Inc. — Investor Relations & Filings

Ticker · 217330 ISIN · KR7217330000 KO Manufacturing
Open in API
Filings indexed 437 across all filing types
Latest filing 2021-05-10 Director's Dealing
Country KR South Korea
Listing KO 217330

About Cytogen, Inc.

https://www.cytogenlab.com/

Cytogen, Inc. is a biotechnology company specializing in liquid biopsy platforms for precision oncology. The company has developed proprietary technology for the rapid isolation and analysis of viable Circulating Tumor Cells (CTCs) from whole blood. Its core offering, the SmartBiopsy Platform, utilizes a high-density microporous chip with microfluidics and nanotechnology to capture CTCs efficiently. This non-invasive diagnostic approach is designed to support early cancer detection, treatment monitoring, and the advancement of personalized medicine for cancer patients.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (FSS) and Korea Exchange. This is a standard regulatory filing in South Korea used to disclose insider trading or changes in shareholdings by company directors and major shareholders. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS) as it reports personal share transactions by company executives/major shareholders.
2021-05-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required when an entity or individual acquires a significant stake (typically 5% or more) in a publicly traded company. According to the provided definitions, this corresponds to a 'Major Shareholding Notification' (MRQ). The document details the reporting entity (Ascent Bio Fund), the target company (Cytogen), the number of shares held, the percentage of ownership, and the purpose of the holding (simple investment).
2021-04-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the acquisition of shares by a major shareholder (AscentBioFund) in Cytogen (주)싸이토젠. This type of filing is a regulatory requirement for major shareholders to disclose changes in their holdings, which falls under the category of 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Amendment Report). It details changes to stock option grants for a specific director (박재찬) due to resignation. This type of filing relates to corporate governance and capital structure changes regarding executive compensation and equity incentives. Since it does not fit into specific categories like 'DEF 14A' (which is typically for proxy statements) or 'DIRS' (which is for insider trading of existing shares), and it is a formal regulatory disclosure filed with the Financial Supervisory Service/Korea Exchange, it is best classified as a Regulatory Filing (RNS).
2021-03-31 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is specifically a '정정신고' (Correction Report) regarding previously granted stock options. This document details changes to the number of shares granted and the list of recipients due to employee resignations. In the context of financial filings, announcements regarding stock option grants, amendments, or cancellations are classified under 'Regulatory Filings' (RNS) as they do not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for capital changes).
2021-03-31 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. It details the acquisition of shares in the company 'Cytogen' (싸이토젠) by 'Ascent Bio Fund' (어센트바이오펀드). This type of filing is specifically used to notify the market when an entity's shareholding crosses a significant threshold (typically 5%), which corresponds to the 'Major Shareholding Notification' category.
2021-03-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.